Cryoport (CYRX) to Release Quarterly Earnings on Thursday

Cryoport (NASDAQ:CYRXGet Rating) will post its quarterly earnings results after the market closes on Thursday, May 5th. Analysts expect Cryoport to post earnings of ($0.18) per share for the quarter.

Cryoport (NASDAQ:CYRXGet Rating) last released its quarterly earnings results on Thursday, February 24th. The consumer goods maker reported ($1.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($1.17). The company had revenue of $56.44 million for the quarter, compared to the consensus estimate of $57.61 million. Cryoport had a negative return on equity of 12.00% and a negative net margin of 123.77%. The business’s revenue was up 16.7% compared to the same quarter last year. During the same quarter last year, the company posted ($0.28) EPS. On average, analysts expect Cryoport to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

CYRX opened at $23.26 on Friday. The company has a market cap of $1.16 billion, a PE ratio of -3.92 and a beta of 1.07. The stock has a 50-day moving average of $31.45 and a 200-day moving average of $49.63. Cryoport has a 52-week low of $21.61 and a 52-week high of $86.30. The company has a debt-to-equity ratio of 0.64, a quick ratio of 15.88 and a current ratio of 16.26.

In other news, CFO Robert Stefanovich sold 1,095 shares of Cryoport stock in a transaction that occurred on Wednesday, March 9th. The shares were sold at an average price of $31.05, for a total value of $33,999.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jerrell Shelton sold 3,298 shares of Cryoport stock in a transaction that occurred on Wednesday, March 9th. The shares were sold at an average price of $31.05, for a total transaction of $102,402.90. The disclosure for this sale can be found here. Over the last quarter, insiders sold 5,803 shares of company stock worth $180,183. Corporate insiders own 9.70% of the company’s stock.

Several large investors have recently bought and sold shares of the company. BlackRock Inc. raised its stake in shares of Cryoport by 1.7% in the fourth quarter. BlackRock Inc. now owns 2,968,392 shares of the consumer goods maker’s stock valued at $175,642,000 after acquiring an additional 49,204 shares during the last quarter. Morgan Stanley raised its position in Cryoport by 20.3% in the 2nd quarter. Morgan Stanley now owns 321,903 shares of the consumer goods maker’s stock worth $20,311,000 after purchasing an additional 54,375 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Cryoport by 80.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 210,859 shares of the consumer goods maker’s stock worth $12,477,000 after purchasing an additional 94,076 shares during the last quarter. Norges Bank bought a new position in Cryoport in the 4th quarter worth approximately $10,525,000. Finally, Millennium Management LLC raised its position in Cryoport by 411.0% in the 4th quarter. Millennium Management LLC now owns 126,059 shares of the consumer goods maker’s stock worth $7,459,000 after purchasing an additional 101,388 shares during the last quarter.

Several analysts have recently issued reports on the company. B. Riley decreased their price target on Cryoport from $94.00 to $70.00 in a research note on Wednesday, March 2nd. TheStreet downgraded Cryoport from a “c-” rating to a “d+” rating in a research note on Friday, January 28th. Roth Capital raised Cryoport from a “neutral” rating to a “buy” rating and set a $90.00 price objective for the company in a research report on Wednesday, January 19th. Needham & Company LLC reissued a “buy” rating and issued a $45.00 price objective on shares of Cryoport in a research report on Wednesday, April 13th. Finally, Zacks Investment Research downgraded shares of Cryoport from a “hold” rating to a “strong sell” rating in a report on Thursday, March 10th. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $75.14.

About Cryoport (Get Rating)

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle.

See Also

Earnings History for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.